You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 265 No. 24, June 26, 1991 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Use of Surveillance for Invasive Pneumococcal Disease to Estimate the Size of the Immunosuppressed HIV-Infected Population

Anne Schuchat, MD; Claire V. Broome, MD; Allen Hightower, MS; Samuel J. Costa, MA; William Parkin, DVM, DrPH

JAMA. 1991;265(24):3275-3279.


Abstract

We used population-based surveillance in New Jersey in 1986 to quantify the risk of invasive pneumococcal disease in persons with the acquired immunodeficiency syndrome (AIDS) and in those who went on to develop AIDS. Using pneumococcal surveillance, we also devised a method to estimate the size of the immunosuppressed population infected with the human immunodeficiency virus (HIV), the so-called pre-AIDS population. From rates of pneumococcal disease that occurred in areas with a low incidence of AIDS, we calculated the number of patients expected to contract pneumococcal disease in areas with a high incidence of AIDS. There were 59 more cases of pneumococcal disease observed than expected; 14 of these patients had AIDS by the time of pneumococcal infection. We attributed the remaining 45 cases to the increased risk of pneumococcal infection in pre-AIDS. The pre-AIDS pneumococcal cases and the attack rate of pneumococcal disease in pre-AIDS were used to estimate the size of the 1986 pre-AIDS New Jersey population as 8823 pre-AIDS cases (95% confidence interval, 7377 to 10 714) or 0.37% of the adult New Jersey population. Surveillance for marker diseases may provide a simple, independent method of estimating the pre-AIDS population.

(JAMA. 1991;265:3275-3279)



Author Affiliations

From the Meningitis and Special Pathogens Branch (Drs Schuchat and Broome) and Statistical Services Activity (Mr Hightower), Division of Bacterial and Mycotic Diseases, Center for Infectious Diseases, Centers for Disease Control, Atlanta, Ga; and Division of AIDS Prevention and Control, Data Analysis Unit (Mr Costa), and Division of Epidemiology and Disease Control (Dr Parkin), New Jersey State Department of Health, Trenton.


Footnotes

Presented in part at the 29th Interscience Conference on Antimicrobial Agents and Chemotherapy, Houston, Tex, September 18, 1989, and at the 63rd annual meeting of the American Epidemiological Society, Baltimore, Md, March 22,1990.

Reprint requests to Meningitis and Special Pathogens Branch, Bldg 1, Room 4415, Mailstop C09, Centers for Disease Control, Atlanta, GA 30333 (Dr Schuchat).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Changes in Invasive Pneumococcal Disease among HIV-Infected Adults Living in the Era of Childhood Pneumococcal Immunization
Flannery et al.
ANN INTERN MED 2006;144:1-9.
ABSTRACT | FULL TEXT  

Epidemiology of Invasive Streptococcus pneumoniae Infections in the United States, 1995-1998: Opportunities for Prevention in the Conjugate Vaccine Era
Robinson et al.
JAMA 2001;285:1729-1735.
ABSTRACT | FULL TEXT  

Infections in AIDS: Proceedings of the Sixth Liverpool Tropical School Bayer Symposium on Microbial Diseases held on 6 February 1999
HART et al.
J Med Microbiol 2000;49:947-967.
FULL TEXT  

Evaluation of Effectiveness of the 23-Valent Pneumococcal Capsular Polysaccharide Vaccine for HIV-Infected Patients
Breiman et al.
Arch Intern Med 2000;160:2633-2638.
ABSTRACT | FULL TEXT  

Epidemiologic Relation between HIV and Invasive Pneumococcal Disease in San Francisco County, California
Nuorti et al.
ANN INTERN MED 2000;132:182-190.
ABSTRACT | FULL TEXT  

Invasive Pneumococcal Infection in Baltimore, Md: Implications for Immunization Policy
Harrison et al.
Arch Intern Med 2000;160:89-94.
ABSTRACT | FULL TEXT  

Depressed Phagocytosis and Oxidative Burst in Polymorphonuclear Leukocytes from Individuals with Pulmonary Tuberculosis with or without Human Immunodeficiency Virus Type 1 Infection
Shalekoff et al.
CVI 1998;5:41-44.
ABSTRACT | FULL TEXT  

Invasive Haemophilus influenzae Infections in Men With HIV Infection
Steinhart et al.
JAMA 1992;268:3350-3352.
ABSTRACT  

Pneumococcal Disease during HIV Infection: Epidemiologic, Clinical, and Immunologic Perspectives
Janoff et al.
ANN INTERN MED 1992;117:314-324.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.